The effect of cardiac rehabilitation on reverse cholesterol transport

The effect of moderate resistance training on lymphocytes ABCA1 gene expression and some of the heart function parameters among male patients with coronary artery disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016050827803N1

Enrollment

Registered

2016-09-22

Start date

2016-06-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis. Atherosclerotic heart disease

Interventions

Intervention 1: Intervention group: in moderate resistance training group, all subjects should participate in moderate resistance training with 40-60% intensity of one repetition Maximum (1RM) through

Rehabilitation

Intervention group: in moderate resistance training group, all subjects should participate in moderate resistance training with 40-60% intensity of one repetition Maximum (1RM) through 60-minute sessi

Control group: in non training group, all subjects do not participate in any physical activity or training.

Eligibility

Sex/Gender

Male

Age

45 Years to 66 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Coronary artery male patients (Atherosclerosis)" without any training experience. Exclusion criteria: Coronary artery male patients (Atherosclerosis)" that cannot participate in 8-week moderate resistance training or do not have regular participation in exercise.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Apolipoprotein A1. Timepoint: 48 hours before intervention and two months after intervention. Method of measurement: ELISA Test.;ATP-binding cassette transporter A1 (ABCA1) Gene. Timepoint: 48 hours before intervention and two month after intervention. Method of measurement: Polymerase chain reaction (PCR) Method.;High-density lipoprotein (HDL). Timepoint: 48 hours before intervention and two month after intervention. Method of measurement: Colorimetric Method.;Low-density lipoprotein (LDL). Timepoint: 48 hours before intervention and two month after intervention. Method of measurement: Colorimetric Method.;Heart function. Timepoint: 48 hours before intervention and two month after intervention. Method of measurement: Echocardiography.	—

Measure

Time frame

Apolipoprotein A1. Timepoint: 48 hours before intervention and two months after intervention. Method of measurement: ELISA Test.;ATP-binding cassette transporter A1 (ABCA1) Gene. Timepoint: 48 hours before intervention and two month after intervention. Method of measurement: Polymerase chain reaction (PCR) Method.;High-density lipoprotein (HDL). Timepoint: 48 hours before intervention and two month after intervention. Method of measurement: Colorimetric Method.;Low-density lipoprotein (LDL). Timepoint: 48 hours before intervention and two month after intervention. Method of measurement: Colorimetric Method.;Heart function. Timepoint: 48 hours before intervention and two month after intervention. Method of measurement: Echocardiography.

—

Secondary

Measure	Time frame
-. Timepoint: -. Method of measurement: -.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Rashid Lamir

Ferdosi Uninversity

Amir.rashidlamir@gmail.com+98 15 3880 4000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026